Table 2.
Patient characteristics for patients from the nutrition-fatigue clinic and the matched control patients
| Nutrition-fatigue clinic (n = 52) | Control patients (n = 52) | p value | |||
|---|---|---|---|---|---|
| Age, years | |||||
| Median | 63 | 64 | |||
| Range | 25–86 | 26–81 | 0.35 | ||
| Sex | |||||
| Male | 31 | 31 | |||
| Female | 21 | 21 | 0.99 | ||
| Primary tumor site | N | % | N | % | |
| Gastrointestinal n (%) | 16 | 31 | 16 | 31 | |
| Urogenital n (%) | 2 | 4 | 2 | 4 | |
| Lymphoma n (%) | 6 | 12 | 6 | 12 | |
| Breast n (%) | 4 | 8 | 4 | 8 | |
| Lung n (%) | 11 | 21 | 11 | 21 | |
| ENT n (%) | 3 | 4 | 3 | 4 | |
| Prostate n (%) | 9 | 17 | 9 | 17 | |
| Mesothelioma n (%) | 1 | 2 | 1 | 2 | |
| C-reactive protein (CRP, mg/l) | |||||
| Median | 13 | 11 | 0.68 | ||
| Range | 1–115 | 1–132 | |||
| Mean body mass index (kg/m2) | 22.4 ± 3.7 | 24.9 ± 3.7 | 0.0001 | ||
| Range | 14.5–31.3 | 17.3–34.3 | |||
| Patients with weight loss ≥2% in prior 2 months (N/%) | 28/70 % | 28/70 % | |||
| Mean value of weight loss in prior 2 months (%) | 4.7 | 2.8 | 0.056 | ||
| Range | −8.9–32.9 | −3.8–14.8 | |||